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An analytical method is described for the separation 01' bradykinin, Lys-
bradykinin. and Met- Lys- bradykinin by equilibrium chromatography on SP-
Sephadex C-25 eluted in 0.02 M Tris-HCl butler. pH 8.10. 0,12 M NaCI. 
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as a second parameter for the identilkation of bradykinin and also separates 
the hormone from plasma bradykinin-potentiating peptides. Ten to one-hundred 
nanomoles of each peptide can be recovered in high yields. identified by 
elution position. and measured by bioassay with the isolated guinea pig 
ileum. The identification of bradykinin as the peptide released by trypsin acting 
on acid-denatured plasma is documented as an illustration of the method. 
The group of structurally related vasoactive polypeptides bradykinin. 
Arg-Pro- Pro-Gly-Phe-Ser-Pro- Phe-Arg (K-9), Lys-bradykinin 
(K-IO), and Met-Lys-bradykinin (K-Il) constitutes 1-2% of the poly-
peptide chain of kininogen, an inactive precursor protein present in 
plasma. These peptide hormones can be released by several proteolytic 
enzymes including trypsin, kaUikrein, plasmin, acrosin, pepsin, and some 
snake venom proteases. Further hydrolysis by aminopeptidases can 
convert Lys-bradykinin and Met-Lys-bradykinin to the limit product, 
bradykinin. Since the three peptides have vastly different specific activi-
ties for contraction of smooth muscle, increase of vascular permeability, 
and depression of systemic blood pressure, the combination of the 
specificity ofthe releasing enzymes, the subsequent conversion by amino-
peptidases, and the different rates of inactivation provides a mechanism 
for the modulation of the activity of these hormones in circulation and in 
tissue [cf. Refs. (2-4) for reeent reviews]. 
The analytical problems associated with desalting, identifying and 
measuring nanomole quantities of each peptide, have limited the attempts 
to determine levels of each of these hormones in various physiological 
and pathologieal conditions. These problems have also hindered studies 
of the specificity and the kinetics of the enzymes which hydrolyze 
these peptide and protein substrates. 
In the aecompanying paper (5), we showed that AG lIAS ion-retarda-
tion resin effectively separates nanomole quantities of kinins from salts 
and buffer ions present in ethanol extraets of trypsin-treated plasma 
prepared under the conditions described by Diniz and Carvalho (6) for 
the determination of human plasma kininogen. In this paper, we describe 
the properties of an equilibrium ehromatography system using SP-
Sephadex C-25 for the separation and identification of K-9, K-IO, 
and K-Il. The AG 1I A8 and SP-Sephadex C-25 systems taken together 
provide an analytical method for the identifieation of kin ins at the nano-
mole level, which is illustrated by application to the identification of 
the kin ins released by trypsin acting on human plasma. 
MA-rERIALS 
Valves, timers, and fittings were purehased from M.E.R. Chromato-
graphie, Mountain View, Calif., and sampIe holders were manufactured 
by Aquebogue Machine Shop, Aquebogue. N. Y. The microbore column 
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and fittings were purchased from Chromatronix, Inc .. Berkeley, Calif. 
Polyethlene glycol was obtained from Fisher Scientific Co., Pittsburgh, 
Pa. SP-Sephadex C-25 is a product of Pharmacia Fine Chemicals, 
Piscataway, N. J. a-Chymotrypsin (CDn and carboxypeptidase B 
(COBDFP) were products ofWorthington Biochemieals, Freehold, N. J. 
All glassware and columns were treated with Siliclad (Clay Adams. 
Parsippany, N. J.). All other chemicals were reagent grade or have 
been described in Refs. (5,7). 
METHODS 
Apparatus. Sampie application, column development, resin regenera-
tion, and resin equilibration are carried out automatically with an ap-
paratus assembled from commercially available parts. Reservoirs con-
taining buffer or 0.1 N NaOH are connected with 11 H-in.-o.d. x 1/16-in.-i.d. 
Teflon or polyethylene tubing, thraugh a motor-driven three-inlet valve 
(M.E.R. No. MV-4), to a Milton-Roy minipump (No. 196-31). The 
buffer is introduced to inlets 1 and 3, and inlet 2 is used for 0.1 N NaOH. 
The motor valve is controlled by a dual timer (M.E.R. No. T-300) to 
provide buffer. 0.1 N NaOH. followed by the same buffer to the pump 
for preselected periods oftime. Aseparate timer (Dimco-Gray Company, 
Model No. 176, 15 hr) and relay are used to contral the total operating 
time of the pump. The outlet of the pump is fitted with a tee connector 
(M.E.R. No. 4040) to accomodate apressure gauge (M.E.R. No. 6060). 
A line filter assembly (M.E.R. No. TF-12) containing porous Teflon 
disks (M.E.R. No. 313, 50 fLm) is connected to the second port of the 
tee to provide back pressure for the pump and to filter buffer solutions. 
A sampie tube (Kel-F, Aquebogue Machine Shop) is located between 
the line filter and the 0.28 x 50-ern column (Chromatronix No. MB-3-500). 
The stainless steel bed-support disk supplied with the column was re-
placed by a porous Teflon support. The sample tube (1-, 3-, or 4.5-ml 
capacity) is c10sed with a semiball connector held in place by two c1amps 
[cL Fig. 1 in ReL (8)]. Teflon tubing, 1/16 in. o.d. x 11:32 in. o.d., is used 
for all lines after the pump and connections are made with fittings ob-
tained from Chromatronix or the equivalent. Alternate apparatus may 
be used to operate the columns; however, the sampie tube system (8) 
li ne with the column provides convenient and reproducible addition of 
measured volumes of large sampies to the column. 
Co/tlmn preparation. SP-Sephadex is equilibrated by suspending the 
resin in 10 vol of buffer, correcting the pH, and resuspending the 
slurry (after decantation) three times in 5 vo) of buffer. The suspension 
is gently stirred with a magnetic stirring bar. Vigorous agitation should 
be avoided, for it produces fine particles. The suspension is degassed 
on a water pump in order to prevent bubble formation while pouring the 
column. The column is filled halfway with buffer. and thc flow is stopped 
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by raising the outlet tube above the liquid level in the column. A dilute 
suspension of the resin is introduced into the column below the liquid 
level from a beaker through a polyethylene tube by siphon action. The 
slurry must be dilute to prevent dumping of the resin and to permit 
small air bubbles to rise to the top of the column. After 2-3 cm of column 
bed has been formed, flow is started from the bottom of the column by 
lowering the outlet tube. The column must be completely filled with resin 
to prevent formation of a buffer space which would dilute the sampie 
during application. The resin is taken through one complete cyde 
(sampie buffer application. development, regeneration. and equilibra-
tion) to stabilize the resin bed. It is usually necessary to add 1-2 cm of 
additional resin to the bed. The operating back pressure of the system 
was usually less than 5 psi, due primarily to the porous Teflon disks 
in the buffer filters. Occasionally, back pressure >50 psi developed 
during sampie application, due to dogging of the bed support disk at 
the bottom of the column. The disk must be replaced, and the column 
must be repoured. 
Buffers. The two buffer systems which proved best for the applica-
tions described here were: (A) 0.02 M Tris-HCI buffer, pB 8.10, 0.12 M 
NaCL and (B) 0.02 M Tris-BCI buffer, pB 7.70. 0.06 M NaCI. Be-
cause the elution positions of the peptides are extremely sensitive to 
NaCI concentration and pB, the buffers were prepared in 2-liter batches 
and were stored at 4°C to assure sufficient buffer for 10-20 columns. 
The conductivity and pB of a fresh buffer were compared directly 
with the buffer previously used, and the fresh buffer was discarded if 
not identical. Buffer A, pH 8.10, provided good resolutions of kinins 
9, 10, and 11 (cf. Fig. 1), but the leading edge of the K-9 profile contained 
small amounts of bradykinin-potentiating peptides produced by the action 
of trypsin on plasma proteins (9.10). Buffer B, pH 7.70, provided com-
plete separation of K-9 from bradykinin-potentiating peptides liberated 
from plasma proteins by trypsin (cf. Fig. 3), but was not useful for the 
determination of kinins 10 and 11 because they were greatly retarded. 
Experimental sampies were analyzed with both buffer systems. 
Column operation. The sampie is diluted in appropriate buffers to give a 
final concentration of 0.05 M MOPS-Hel buffer,R pH 7.0, and 15% (viv) 
polyethylene glycol 400. PEG is added for "Iayering" during sampie 
application (8). A measured aliquot of the sampie (0.5-4.0 ml) is trans-
ferred to the sampie tube with a micropipet, and the volume remaining 
is completed with 0.05 M MOPS-HCl buffer, pH 7.0, which does not 
contain PEG. The sampie buffer and column operating conditions are 
the same for pH 7.70 and 8.10 developing buffers. The column is operated 
"Abbreviations used: MOPS, morpholino-propanesulfonic acid: PEG, polyethylene 
glycol. 
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under equilibrium conditions after sampie application at 25°C at 6 mUhr, 
and I-mi fractions are collected. The column is regenerated at the end 
of the run with 3 ml of 0.1 N NaOH and is equilibrated with 60 ml of 
developing buffer. 
The void volume (Vo) of the SP-Sephadex column was determined 
with 15 p,mol of cysteic acid and 15 p,mol of sodium phosphate in 4.0 
ml of 0.05 M MOPS-HCl buffer, pH 7.0. containing 15% (v/v) poly-
ethylene glycol. Fractions of 0.2 ml were collected. Cysteic acid and 
phosphate were detected in O.I-ml aliquots ofthe effluent by reaction with 
ninhydrin (11) and by mixture with an equal volume of a saturated solution 
of barium chloride. respectively. 
lsolated guinea pig ileum assay for kinins. Kinin activity was deter-
mined by measuring the isotonic contraction of isolated guinea pig 
ileum suspended at 37°C in aerated Tyrode solution containing 3.5 
x 10-7 M atropine and 1. 7 x 10-6 M diphenylhydramine. The measurement 
of K-9. K-IO. and K-ll was done by direct matching of the extent of 
contraction with standard solutions of the appropriate peptide. The con-
centration of peptide in standard solutions was determined by amino 
acid analysis after acid hydrolysis (5). Aliquots of up to 0.5 ml of column 
effluent, containing 0.02 M Tris-HCl buffer and varying amounts of 
NaCl up to 0.15 M at pH 7.70 or 8.10. can be assayed directly on the 
isolated guinea pig ileum (IO-ml incubation volumel without interfering 
with the assay. The potentiating peptides were located in the column 
efftuent by a qualitative assay similar to the quantitative assay described 
by Ferreira et al. (12). Conversion of K-Il to K-9 was carried out in the 
pH 8.1 column efftuent by the addition of trypsin (5 p,g!ml). Control 
experiments were performed in parallel with synthetic K-l1 at the same 
concentration. 
En::.ymatic inactivation of bradykinin. The column effluent correspond-
ing to the elution position of bradykinin was pooled and treated either with 
ex-chymotrypsin (10 p,g/ml) or carboxypeptidase B (6.0 p,g!ml) at 37°C. 
The rate of inactivation was compared with that of synthetic bradykinin 
at the same concentration in the same buffer. The isolated guinea pig 
ileum bioassay was used to measure the residual bradykinin activity. 
Determination ofthe limit ofdetectionfor bradykinin, Lys-bradykinin, 
and Met-Lys-bradykinin. The peptides (0.2-10 nmol in a 4-ml sampIe 
buffer) were chromatographed individuallyon SP-Sephadex at pH 8.1. 
The efftuent was monitored by bioassay using up to 0.5 ml of efftuentlassay. 
Variability in the sensitivity of the ileum from different animals made it 
necessary to select. for these experiments, tissue which would respond 
to 0.02 nmol of bradykinin with a full-scale deflection of the chymograph. 
Release of kinin act;rity hy trypsin treatment (~f acid-denatured 
human plasma. The experimental conditions for the release of kin in 
activity and desalting on AG 11A8 resin are given in Ref. (5). 
374 SAMPAIO Er AL. 
RESULTS 
Eqllilibrillm Chromatography 01 K-9, K·IO, and K-ll on SP-Sephadex 
C-25 
The experimental conditions for equilibrium chromatography were de-
termined, in aseries of test tube experiments, to measure the distribution 
coefficient of the peptides between the liquid and resin phases as a 
function of pH and ionic strength (13) and were then refined in column 
experiments. The concentration of Tris-HCI buffer was arbitrarily set 
at 0.02 M to permit the use of aliquots containing as much as 0.5 ml of 
column efftuent for bioassay of kinins with the isolated guinea pig 
ileum. The void volume ofthe column (Vo), determined with cysteic acid 
and phosphate. was 1.2 ml of both the pH 7.70 and 8.10 buffers. The 
total volume of the column (V T)' determined volumetrically, was 3.0 ml. 
The elution diagram given in Fig. 1, top, was obtained with 0.02 M 
Tris-HCl buffer, pH 8.10, containingO.12 M NaCl. The transmission at 206 
nm is given in Fig. 2B. Bradykinin. Met-Lys-bradykinin, and Lys-brady-
kinin are eluted at 20, 38, and 56 ml. The recovery of biological activity 
was generally 70-90% for 10- to IOO-nmol sampIes. The elution volume 
between the peptides is sufficient to permit quantitation without inter-
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FIG. I. Equilibrium chromalography 01' synthetic bradykinin. Lys-bradykinin. amI 
Met-Lys-bradykinin (top) and the kinin released by trypsin acting on acid-denatured 
human plasma (bottom) on SP-Sephadex C-25 at pH 8.10. The column, 0.3 x 50 cm. 
was developed with 0.02 M Tris-HCI buffer. pH 8.10. 0.12 M NaCI at 6 ml/hr. 25°C. 
Top: The sampie contained 25. 40. and 90 /-Lg of bradykinin. Lys-bradykinin. und Met 
Lys-bradykinin. respectively. Bottom: The sampie was derived from 6 ml of plasma 
and had been desalted on AG 11 A8 resin. It contained 24 /-Lg of bradykinin equivalents. 
Biological activity was determined with the isolated guinea pig ileum assay. 
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FIG. 2. Effect of sodium chloride concentration on the equilibrium chromatography 
of kinins. The column was operated as described in the legend to Fig. l. The elution 
buffer contained 0.02 M Tris-~{cl buffer, pH 8. JO and: (Al 0.11 M NaCI; (Bl 0.12 M 
NaCI; (Cl O. \3 M NaCI; and (0) 0.15 M NaCI. The sampies were the same as those 
described for Fig. I, top. Transmission at 206 nm was determined with a Uvicord 111 
using a microftow cell. 
ferenee due to overlapping. Approximate values for K 3V' 9 the distribu-
tion eoeffieient (14), are: bradykinin, 10; Met-Lys-bradykinin, 20; and 
Lys-bradykinin, 30. The eomponent eluted at 30 ml, deteeted by bio-
logical activity and absorbanee at 206 nm, was present only in the Met-
Lys-bradykinin sampie and may be a result of the oxidation of the sulfur 
in the methionine residue. 
When elution is carried out with 0.02 M Tris-HCl buffer, pH 7.70, 
0.06 M NaCl, bradykinin is eluted at 36 ml (Fig. 3, top). The K 3V is 19, 
which is almost twice that obtained with the pH 8.10 buffer. The pH 7.70 
buffer is used both as a seeond chromatographie parameter to identify 
bradykinin and to separate small amounts of potentiating peptides from 
bradykinin (Fig. 3, bottom) whieh are eluted on the ascending limb of the 
bradykinin peak at pH 8.10. The recovery of synthetic bradykinin was 
generally 70-90% for sampies of 10-100 nmol. This buffer system i5 not 
useful for the identification of Lys-bradykinin and Met-Lys-brady-
kinin, because they are greatly retarded, and the peaks are too wide for 
useful quantitation. 
9Kav~ ve VjV t - V". where Ve is the elution volume of the peak tube minus 
the volume of the connecting Teflon tubing (1.0 ml): V" is void vo1ume (1.2 ml). and 
VI is the total bed volume 0.0 ml). 
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FIG. 3. Equilibrium chromatography of the synthetic bradykinin (top) and the kinin 
released by trypsin acting on acid-denatured human plasma (bottom) on SP-Sephadex 
C-25 at pH 7.70. The column, 0.3 x 50 cm, was developed with 0.02 M Tris-HCI 
buffer, pH 7.7, 0.06 M NaCI at 6 ml/hr, 25°C. The sampies were: (top) 20 Jlg of brady-
kinin; (bottom) tryptic hydrolysate derived from 5 ml of plasma and containing 20 Jlg of 
bradykinin equivalents. Biological activity was determined with the isolated guinea pig 
ileum assay. 
Elfects of Operating Conditions 
The equilibrium chromatography of these structurally related peptides 
is extremely sensitive to the operating conditions. Variations of ±0.10 
pH unit of the buffer affect the separation of kinins 10 and I I, The efJect 
of some experimental conditions on the separation ofthe kinins at pR 8,10 
is documented below, 
NaCI Concentration 
Figure 2A-D shows that the elution position and peak width of each 
peptide are extremely sensitive to the NaCI concentration of the eluting 
buffeT. The experiments were carried out with 0,02 M Tris-RCI buffer, 
pR 8.10. The variation in NaCI concentration from 0.11 to 0.15 M is 
reftected in the change of elution position of K-IO from 72 ml 41 ml, 
respectively. The effect is not as large for K-ll (48-30 ml) and is small 
for K-9. Band broadening is observed when the retention volume is in-
creased. In order to have a rapid analysis with acceptable baselines 
between K-ll and K-lO, we use 0.12 M NaCI (Fig. 2B). However, the 
0.11 M N aCI is useful for the complete separation of the contaminant 
present in the commercial sampies of K-l1 which is eluted at 30 ml 
(cf. Fig. 2A). The use ofbuffer containing 0.15 M NaCI provides a more 
rapid analysis and an increase in sensitivity because there is less dilution 
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of the sohlte, but the separation of peptides is not complete. The effect 
of excess salt in the sampIe solution is to cause K-9 to be eluted 
more rapidly and. sometimes, as a double peak, whereas there is usually 
little or no effect on the elution of K-lO and K-ll. 
FloH' Rate 
The elution diagrams shown in Fig. I were obtained at a flow rate of 
6 ml/hr (1.4 mUcm2/min) and required 11 hr for a complete analysis. 
When the flow rate was reduced to 3 mllhr, a narrowing of the elution 
profiles was observed. Attempts to increase the flow rate to 12 ml/hr 
caused an irreversible compression of the resin. 
Temperature 
In order to test the effect oftemperature on the chromatographie system, 
the column was operated at 20, 25, and 30°C with pH 8.10 buffer pre-
pared at 21°e. The elution of the three kinins was retarded when the 
temperature was increased. The maximum retardation was 4.0 ml for K-IO. 
There was no detectable effect of temperature on the width of the elu-
tion profile for each peptide. 
Multiple Use 0/ the Same Coltln/Tl 
The effect of repeated cycling of the column, development, regenera-
tion with NaOH, and re-equilibration of the resin, was tested by moni-
toring the elution diagram obtained after 13 complete cycles. No effect 
on the resolution, reproducibility, or recovery of peptides was ob-
served. 
Samp/e Vollllne 
Sampies are applied in 0.05 M MOPS~HCI buffer, pH 7.0, con-
taining 15% PEG (viv) to both the pH 8.10 and 7.70 eolumns. By reducing 
the pH and ionie strength of the sampie solution below that of the 
equilibrating buffer, 0.5~4.0 ml sampies ean be applied to the 0.28 x 50-
cm column which has a void volume of 1.2 ml. In separate experiments 
not illustrated here, elution diagrams for a mixture of the three peptides 
were obtained for 1-, 2-, 3-, and 4-ml sampIes applied with 1-, 2-, 3-, and 
4-ml sam pIe tubes. As the sampIe volume increased from 1 to 4 ml. 
the elution volume for each peptide increased 4 mllml of sampIe volume, 
and there was some widening of the elution envelope. We used the 
same sampie tube, and the variations in sampie volume (MOPS~HCI 
buffer containing PEG) are eompensated for by the addition of MOPS-
HCI buffer without PEG. In this way, the total volume of MOPS-HCI 
buffer applied to the eolumn is eonstant, though the sampie volume is 
variable (8). The effieaey of the sampIe application tube and the use of 
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PEG in tbe sampIe solution are indicated by tbe observation that a 
4.0-ml sam pIe of cysteic acid is eluted in a total volume of 4.2 ml. 
Recovery 0/ Actil'ity and Limit 0/ Detection 
The recovery of biological activity from tbe SP-Sephadex column oper-
ated at pB 8.1 was 70-90% for 10-100 nmol of each peptide with tbe 
isolated guinea pig ileum used for assay. The smallest amount of each 
peptide which could be recovered from the column in yields of 50-90% 
was 0.5, 8.0, and 6.0 for K-9, K-10, and K-ll, respectively. Smaller 
quantities of the peptides could be detected in the effluent, but eould not 
be measured accurately. In this case, when the dis placement in the base-
line value of the bioassay with 0.4 ml of efftuent coincided with the 
eorreet elution position, the efftuent eorresponding to tbe peak tubes 
was pooled and assayed. The lower limit of deteetion for the eomplete 
system, Le., eolumn and ileum bioassay, is 0.2, 4, and 3 nmol for brady-
kinin, Lys-bradykinin, and Met-Lys-bradykinin, respectively (cf. Dis-
cussion seetion). The large difference in tbe limit of detection tür brady-
kinin, as compared to Lys-bradykinin or Met-Lys-bradykinin, is due 
to the lower sensitivity of ileum for the larger peptides (15) and the 
greater dilution of K-lO and K-Il during chromatography. 
Elution Positions 0/ Otlzer Biologically Active Peptides 
Angiotensin land 11 and histamine do not interfere with the identifiea-
tion of bradykinin on the SP-Sephadex column at pB 7.70, for they are 
eluted before bradykinin. Substance P and serotonin are eluted near 
bradykinin. These substances are distinguishable from bradykinin on 
the basis of enzyme inactivation and specifie pbarmacological inhibitors. 
Chromatographie systems for these vasoaetive substanees will be de-
scribed. 10 
ldentification 0/ Kinin Released by Trypsin Acting on Acid-Denatured 
Human Plasma 
Bydrolysates corresponding to 20 and 100% ofthe maximum releasable 
kinin activity were analyzed in order to determine if K-lO and K-ll are 
detectable intermediates in the produetion of K-9. The separation of 
kinin aetivity from salts and buffers present in ethanol extracts of plasmall 
10 M. L. Reis. w. Draghetta. and L. J. Greene. manuscript in preparation. 
11 The AG IlA8 step could not be climinated by diluting the ethanol extract of the 
trypsin hydrolysate with the SP-Sephadex sampie buffer before chromatography. When 
the ethanol extract corresponding to 1 ml of plasma was diluted with 2.5 ml of MOPS 
buffer and was chromatographed at pH 7.70. two peaks of kinin activity which were 
not resolved were obtained. When synthetic bradykinin was chromatographed in the 
presence of 1 ml of extract under the same conditions. the double peak of activity was 
also ohtained. The additional peak was eluted more rapidly. 
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is described in Ref. (5). Eighty-eight percent of the kinin activity was re-
covered in a solution which had 142 Mmho/cm of conductivity at a volume 
equal to that of the plasma from which it was prepared. The con-
ductivity value is equivalent to 1.2 mM NaCI. The kinin activity repre-
sents approximately 0.06% of the weight of material in the fraction after 
desalting, with the remainder probably composed ofpeptides and proteins. 
The elution diagram for the SP-Sephadex equilibrium chromatography, 
at pH 8.1. of a tryptic hydrolysate of human plasma is given in Fig. 1, 
bottom. The sampie contained the maximum releasable kinin activity 
derived from 6 ml of plasma. All of the kinin activity was eluted in the 
position of bradykinin in a 70% yield. Sometimes, a small amount of 
bradykinin-potentiating peptides is eluted between 5 ml and the ascend-
ing limb of the bradykinin peak. Kinin activity was not detected either 
before or after trypsin treatment of a pool of the efftuent corresponding 
to 33 -45 ml. This treatment would have converted K-l1, if it had been 
present, to K-9 with a 10-fold increase in specific activity. Bradykinin 
was also the only kinin detected in a trypsin hydrolysate which had 
been analyzed after 20% of the total potential kinin activity had been 
released. In this experiment, which also indicates that K-I0 and K-ll 
were not detectable intermediates in the early phase of the release of 
K-9. the sampie contained 10 Mg of bradykinin equivalents derived 
from 10 ml ofplasma. Seventy-four percent ofthe biological activity was 
recovered from the SP-Sephadex column. 
Figure 3. bottom, shows the result obtained when an aliquot of the 
trypsin hydrolysate, corresponding to 100% release of kinin activity, 
was chromatographed at pH 7.7. This buffer system provides a second 
equilibrium chromatography parameter for the identification of brady-
kin in and completely separates plasma bradykinin-potentiating peptides 
from bradykinin. The recovery of biological activity was 60% for this 
experiment and 55 ± 10% for six others. The bradykinin-potentiat-
ing peptides are eluted in the efftuent from 4 to 17 mJ. The low re-
covery of acti vity for both columns is accounted for, in part, by the separa-
tion of plasma bradykinin-potentiating peptides from bradykinin, which 
would lead to an overestimation of the kinin activity in the mixture 
when the bioassay is used (9,10). On the basis of the recovery of brady-
kinin from the SP-Sephadex column at pH 7.70, we estimate that approxi-
mately 25-30% of the apparent kinin activity present in the trypsin 
hydrolysate of human plasma is due to the bradykinin-potentiating 
peptides. On this basis, human plasma contains 4.0-4.5 Mg of brady-
kinin equivalents/ml of plasma rather than the 6.0 ± 0.7 Mg/mi obtained 
by bioassay of the hydrolysate. Louhija and Sipilä (16), who used 
IRe-50 resin to separate bradykinin from potentiating peptides and radio-
immunoassay to measure directly the bradykinin in the mixture (17), 
showed that the potentiating peptides account for nearly 50% of the 
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kinin activity and reported values of 3.36 ± 0.49 p.,g of bradykinin 
equivalents/ml of plasma. Estimates based on chromatographie recoveries 
are less accurate than the radioimmunoassay method. 
The kinin activity released by trypsin acting on acid-denatured plasma 
is identified as bradykinin on the basis of its chromatographie behavior 
in two equilibrium chromatography systems. The identification is con-
firmed by experiments with carboxypeptidase Band a-chymotrypsin in 
which the rates of inactivation were equivalent to that of synthetic 
bradykinin. 
DISCUSSION 
The objective of this study was to develop an analyticaI method for the 
identification and measurement of bradykinin and related peptides at 
nanomole levels in physiological solutions and enzymatic hydrolysates. 
Analytical procedure have been described for the separation of the 
three peptides by paper chromatography and paper electrophoresis (18) 
[cf. also Ref. (19) which indicates that reported electrophoretic separa-
tions were not reproduced), high-voltage paper electrophoresis (pyridine-
acetic acid buffer) (20); gel filtration on Sephadex 0-15 (21), and gradient 
elution chromatography on CM-cellulose (22) or CM-Sephadex (23). An 
excellent review and analysis of the chromatographie approaches to the 
problem of extracting, desalting, and separating kinins is given in Ref. (24). 
The method for the equilibrium chromatography of kinins deseribed 
here, when used with the desalting procedure in the accompanying 
paper (5), is more effective and convenient than these other methods for 
complete separation of the peptides and for unambiguous identifica-
tion, measurement, and high recovery of nanomole quantities of these 
peptide hormones from solutions containing large amounts of buffer salts. 
Equilibrium chromatography on SP-Sephadex at pH 8.10 provides an 
extremely selective and reproducible method for the separation and 
identification of the three major kinins. A second parameter for the 
identification of bradykinin, which also separates the hormone from 
plasma bradykinin-potentiating peptides, is obtained by equilibrium 
chromatography at pH 7.70. The chromatographie behavior of these 
peptides is extremely sensitive to pH and ionic strength and, to a lesser 
extent, temperature and flow rate. When the system is standardized 
with synthetic peptides and the operating conditions are held constant, 
reproducible elution diagrams are obtained with columns that can be 
used repeatedly. The large number of combinations of pH and ionic 
strength which are available for equilibrium chromatography of these 
peptides provide the versatility and selectivity needed for the extension 
of this method to the separation of other vasoactive cationic com-
ponents. lfI 
The identification of the kinin released by trypsin acting on acid-
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denatured human plasma is presented as an illustration of an applieation 
of the method to a complex mixture. Webster and Pierce (25) showed 
that bradykinin is the major kinin released from human plasma, and, 
subsequently, Habermann and Belennemann (22) obtained the same result 
with trypsin acting on purified bovine kininogen [cf. Ref. (26)]. The 
small amount of K-IO (2-3%) detected by Webster and Pierce (25) in 
preparative experiments with 500 ml of plasma could not have been 
detected in the analytical experiments reported here. The attempt to 
detect K-ll as an intermediate in the early phase of the reaction (20% of 
maximum release) is complicated both by the fact that K-ll is rapidly 
eonverted to K-9 by trypsin and by the relatively slow sensitivity of 
the guinea pig ileum for K-lI. We estimate that, if the hydrolysate had 
eontained 23% K -11 on a molar basis (37c of the total biologie al 
activity), it would not have been detected in these experiments in 
which hydrolysates containing 10-15 fLg of bradykinin equivalents were 
analyzed. 
The applicability of the system can be improved by increasing the 
sensitivity of the solute-detection system. We have used the isolated 
guinea pig ileum assay because of its stability and reprodueibility, in 
spite of its relatively low sensitivity as compared to other tissue 
preparations or other types of detection systems. For example, the 
isolated rat uterus is at least 20 times more sensitive to bradykinin 
than is the isolated guinea pig ileum and is even more sensitive to 
the other peptides (15). lncreased sensitivity mayaiso be achieved by 
use of the laminar-flow superfusion technique (27), the sensitivity of 
which is near or equal to that obtained by radioimmunoassay. It should 
be possible to combine the selectivity of the separations obtained by 
equilibrium chromatography with the sensitivity achievable with radio 
immunoassay by monitoring the column effluent by radioimmunoassay. 
This would overcome a serious limitation ofthe radioimmunoassay method, 
i.e., the inability to discriminate among the individual kinins when they 
are present in a mixture and simultaneously be insensitive to peptide 
fragments of these hormones (28, 29). 
As the sensitivity of the detection method is improved, the system will 
become more limited to manipulative and chromatographie losses. How-
ever, we believe that a substantial increase in sensitivity, perhaps one 
of several orders of magnitude, can be achieved before these losses be-
come limiting. The inc\usion of radioactivity peptides in the sampie 
solution could have provided not only an accurate and sensitive method 
for the determination of manipulative and chromatographie losses. but 
also an internal standard for elution position. However, we have not 
been able to rechromatograph radioactive HC_ or "H-Iabeled sampies of 
any one of the peptides on SP-Sephadex C-25 without obtaining two 
or three additional more rapidly eluting radioactive components. 
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The SP-Sephadex system developed in our laboratory was used by 
others for the identification of Met-Lys-bradykinin as the product re-
leased by porcine pepsin acting on highly purified human plasma kinino-
gens (30), and to identify the kinins present in human urine and monitor 
their production and conversion by human urinary enzymes (31). 
The ability to separate and measure small quantities of kinins will 
facilitate biochemical studies concerning their formation and inactiva-
tion, and measurements of kinin levels in physiological fluids in a variety 
of physiopathological situations should contribute to an understanding 
of the significance of the kinin system. 
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